Active, not recruitingEarly Phase 1NCT04614909

Study of Pamiparib in Newly Diagnosed and rGBM

Studying Astrocytoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Nader Sanai
Principal Investigator
Nader Sanai, MD, MD
Director, Ivy Brain Tumor Center
Intervention
Pamiparib(drug)
Enrollment
45 target
Eligibility
18 years · All sexes
Timeline
2021 – 2026

Study locations (1)

Collaborators

Barrow Neurological Institute · Ivy Brain Tumor Center · BeiGene

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04614909 on ClinicalTrials.gov

Other trials for Astrocytoma

Additional recruiting or active studies for the same condition.

See all trials for Astrocytoma →

← Back to all trials